News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
886,615 Results
Type
Article (89010)
Company Profile (554)
Press Release (797033)
Multimedia
Podcasts (250)
Webinars (37)
Section
Business (267108)
Career Advice (4167)
Deals (40040)
Drug Delivery (182)
Drug Development (91811)
Employer Resources (208)
FDA (18618)
Job Trends (17503)
News (398967)
Policy (40028)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (7)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (7)
Academia (3069)
Academic (2)
Accelerated approval (60)
ADA (50)
Adcomms (43)
Allergies (213)
Alliances (56991)
ALS (246)
Alzheimer's disease (2052)
Antibody-drug conjugate (ADC) (604)
Approvals (19032)
Artificial intelligence (943)
ASCO (345)
Autoimmune disease (392)
Automation (71)
Bankruptcy (409)
Best Places to Work (12634)
BIO (80)
BIOSECURE Act (23)
Biosimilars (266)
Biotechnology (335)
Bladder cancer (220)
Brain cancer (87)
Breast cancer (874)
Cancer (6913)
Cardiovascular disease (584)
Career advice (3604)
Career pathing (55)
CAR-T (401)
CDC (77)
Celiac Disease (3)
Cell therapy (1122)
Cervical cancer (60)
Clinical research (79539)
Collaboration (2516)
Commercialization (4)
Company closure (8)
Compensation (1621)
Complete response letters (118)
COVID-19 (3047)
CRISPR (130)
C-suite (1402)
Cystic fibrosis (170)
Data (9151)
Decentralized trials (3)
Denatured (96)
Depression (208)
Dermatology (112)
Diabetes (740)
Diagnostics (7696)
Digital health (75)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (479)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (338)
Earnings (102748)
Editorial (81)
Employer branding (25)
Employer resources (178)
Events (139153)
Executive appointments (1249)
FDA (22967)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (23)
Frontotemporal dementia (37)
Funding (2053)
Gene editing (285)
Generative AI (95)
Gene therapy (883)
GLP-1 (1306)
Government (5574)
Grass and pollen (8)
Guidances (429)
Healthcare (21283)
Hematology (198)
HIV (107)
Huntington's disease (73)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (122)
Immunology and inflammation (372)
Immuno-oncology (124)
Indications (231)
Infectious disease (3463)
Inflammatory bowel disease (248)
Inflation Reduction Act (17)
Influenza (156)
Intellectual property (343)
Interviews (823)
IPO (18023)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (27)
Labor market (130)
Layoffs (699)
Leadership (56)
Legal (10172)
Liver cancer (111)
Longevity (38)
Lung cancer (915)
Lymphoma (498)
Machine learning (70)
Management (69)
Manufacturing (1330)
Marketing (10)
MASH (233)
Medical affairs (1)
Medical device (15334)
Medtech (15547)
Mergers & acquisitions (23402)
Metabolic disorders (1904)
mRNA (283)
Multiple sclerosis (217)
NASH (24)
Neurodegenerative disease (553)
Neuropsychiatric disorders (133)
Neuroscience (3907)
Neurotech (2)
NextGen: Class of 2026 (7717)
Non-profit (5150)
Now hiring (85)
Obesity (902)
Opinion (385)
Ovarian cancer (257)
Pain (300)
Pancreatic cancer (379)
Parkinson's disease (434)
Partnered (43)
Patents (704)
Patient recruitment (856)
Peanut (72)
People (68290)
Pharmaceutical (81)
Pharmacy benefit managers (38)
Phase 1 (24567)
Phase 2 (34544)
Phase 3 (25983)
Pipeline (10701)
Policy (409)
Postmarket research (3561)
Preclinical (11018)
Press Release (72)
Prostate cancer (367)
Psychedelics (82)
Radiopharmaceuticals (388)
Rare diseases (1365)
Real estate (7467)
Recruiting (83)
Regulatory (30821)
Reports (78)
Research institute (2782)
Resumes & cover letters (655)
Rett syndrome (47)
RNA editing (31)
RSV (100)
Schizophrenia (200)
Series A (351)
Series B (254)
Service/supplier (15)
Sickle cell disease (135)
Special edition (33)
Spinal muscular atrophy (193)
Sponsored (55)
Startups (4378)
State (2)
Stomach cancer (21)
Supply chain (154)
Tariffs (104)
The Weekly (151)
Vaccines (1343)
Venture capital (144)
Weight loss (611)
Women's health (150)
Worklife (25)
Date
Today (66)
Last 7 days (502)
Last 30 days (2132)
Last 365 days (33367)
2026 (19243)
2025 (33213)
2024 (37863)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1299)
Alabama (106)
Alaska (7)
Arizona (419)
Arkansas (16)
Asia (52522)
Australia (9234)
California (14913)
Canada (4177)
China (1693)
Colorado (641)
Connecticut (657)
Delaware (462)
Europe (121118)
Florida (2248)
Georgia (485)
Hawaii (4)
Idaho (70)
Illinois (1308)
India (114)
Indiana (688)
Iowa (25)
Japan (639)
Kansas (146)
Kentucky (58)
Louisiana (64)
Maine (92)
Maryland (1790)
Massachusetts (10891)
Michigan (430)
Minnesota (832)
Mississippi (7)
Missouri (170)
Montana (37)
Nebraska (31)
Nevada (160)
New Hampshire (92)
New Jersey (3944)
New Mexico (36)
New York (3938)
North Carolina (1972)
North Dakota (11)
Northern California (7465)
Ohio (469)
Oklahoma (29)
Oregon (46)
Pennsylvania (2913)
Puerto Rico (33)
Rhode Island (54)
South America (1671)
South Carolina (92)
South Dakota (2)
Southern California (5889)
Tennessee (243)
Texas (2424)
United States (53236)
Utah (449)
Vermont (2)
Virginia (375)
Washington D.C. (88)
Washington State (1209)
West Virginia (4)
Wisconsin (166)
Wyoming (2)
886,615 Results for "8".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Psychedelics
Lilly’s $3.8B psychedelics bet won’t open the M&A floodgates
Eli Lilly’s $3.8 billion play for AtaiBeckley has fueled speculation that Big Pharma is ready to embrace psychedelics. But while the acquisition does validate the drug class, analysts say it is unlikely to trigger a broad wave of Big Pharma deals.
July 24, 2026
·
3 min read
·
Gabrielle Masson
Press Releases
MindMaze Therapeutics Announces CHF 8.0 Million Strategic Equity Financing
May 26, 2026
·
4 min read
Job Trends
8 companies hiring in Greater Philadelphia
Looking for your next role in Philly? Here are eight companies currently hiring.
July 2, 2026
·
1 min read
·
Chantal Dresner
Press Releases
Cadrenal Therapeutics Announces up to $8.8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
July 1, 2026
·
6 min read
Press Releases
NanoViricides Announces Pricing of ~$3.8 Million Registered Direct Offering
July 24, 2026
·
4 min read
Manufacturing
Samsung Biologics targets $1.8B PolyPeptide buyout to expand in obesity
With PolyPeptide manufacturing peptides such as GLP-1 medicines, Samsung Biologics has identified the deal as a way to tap into fast-growing demand for obesity drug production services.
July 21, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
IBA – ACQUISITION OF OWN SHARES - June 8, 2026
June 9, 2026
·
2 min read
Psychedelics
Lilly makes up to $3.8B psychedelics play in AtaiBeckley takeover
With the AtaiBeckley acquisition, Eli Lilly is jumping into psychedelics, a drug class that Jefferies analysts say could herald the “biggest change” for the field of psychiatry.
July 16, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Novo Nordisk A/S - share repurchase programme - June 8, 2026
June 8, 2026
·
2 min read
Press Releases
Major Shareholder Announcement - May 8, 2026
May 10, 2026
·
3 min read
1 of 88,662
Next
